Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.223.003 |
Chemical and physical data | |
Formula | C11H15NO4 |
Molar mass | 225.244 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |